OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
8
Results
Show all
Save search
Copy query
Show results for
Unknown
(8)
Publication Date
Release Date
2025
(2)
2023
(2)
2022
(2)
2026
(1)
2018
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Not available
S-EPMC11894486
|
biostudies-literature
Cite
Reliability assessment of ultrasound muscle echogenicity in patients with rheumatic diseases: Results of a multicenter international web-based study.
Not available
S-EPMC9886677
|
biostudies-literature
Cite
Impact of Vutrisiran on Quality of Life and Physical Function in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Polyneuropathy.
Not available
S-EPMC10444729
|
biostudies-literature
Cite
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Not available
S-EPMC5972549
|
biostudies-literature
Cite
Human germline heterozygous gain-of-function STAT6 variants cause severe allergic disease.
Not available
S-EPMC10037107
|
biostudies-literature
Cite
Common, low-frequency, rare, and ultra-rare coding variants contribute to COVID-19 severity.
Not available
S-EPMC8661833
|
biostudies-literature
Cite
Oxygenation improvement and duration of prone positioning are associated with ICU mortality in mechanically ventilated COVID-19 patients.
Not available
S-EPMC11775368
|
biostudies-literature
Cite
Obesity rise plateaus in developed nations and accelerates in developing nations.
Not available
S-EPMC13171639
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets